Classification of Pulmonary Embolism
Pulmonary embolism is classified by three key dimensions: severity (based on hemodynamic status and mortality risk), anatomic location (central vs. peripheral), and chronicity (acute vs. chronic thromboembolic disease). 1, 2
Severity Classification
The most critical classification system stratifies PE by hemodynamic stability and mortality risk, which directly guides therapeutic decisions:
High-Risk (Massive) PE
- Hemodynamically unstable with sustained hypotension (systolic BP <90 mmHg for ≥15 minutes or requiring vasopressor support)
- Obstructive shock or cardiac arrest
- This represents the most severe form with right ventricular failure as the primary cause of death 1
- These patients require immediate consideration for systemic thrombolysis or advanced interventional therapy 2
Intermediate-Risk PE
This category is further subdivided based on RV dysfunction and cardiac biomarkers:
- Intermediate-high risk: Evidence of both RV dysfunction (on echocardiography or CT) AND elevated cardiac biomarkers (troponin, BNP)
- Intermediate-low risk: Either RV dysfunction OR elevated biomarkers, but not both
- These patients are hemodynamically stable but have markers suggesting potential decompensation 1, 2
Low-Risk PE
- Hemodynamically stable
- No RV dysfunction
- Normal cardiac biomarkers
- Can be identified using PESI (classes I-II) or simplified PESI score 3
- These patients are candidates for outpatient management or early discharge 1, 2, 3
A critical pitfall: The 2026 AHA/ACC guidelines introduced new "Acute Pulmonary Embolism Clinical Categories" that provide enhanced granularity beyond traditional risk stratification, though these require further validation 2, 4.
Anatomic Location Classification
PE is classified by the most proximal location of thrombus:
Central PE
- Thrombus in the pulmonary trunk or main pulmonary arteries
- Associated with higher rates of RV strain (72.1% vs. 33.3% for peripheral PE) 5
- More frequently classified as intermediate-high or high-risk (63.3% vs. 24.4%) 5
- More likely to receive advanced therapies (thrombolysis 9.8% vs. 2.0%; endovascular therapy 11.3% vs. 0.7%) 5
Peripheral PE
- Thrombus in lobar, segmental, or subsegmental arteries
- Generally associated with lower severity markers 5
Important caveat: While central PE correlates with more severe hemodynamic compromise and RV dysfunction, anatomic location alone does not independently predict mortality when adjusted for other risk factors 5. The severity classification based on hemodynamics and RV function remains the primary determinant of outcomes and treatment decisions.
Chronicity Classification
Acute PE
- Symptoms present for days to weeks
- Characterized by acute dyspnea, pleuritic chest pain, or hemoptysis
- May present with hemodynamic instability in massive cases 6
Subacute Massive PE
- Presents over weeks, mimicking heart failure or indolent pneumonia
- Progressive symptoms without acute hemodynamic collapse 6
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- Slowly progressive dyspnea over months to years
- Results from incomplete resolution of thromboemboli with organized thrombus and vascular remodeling
- Requires different diagnostic and therapeutic approach than acute PE 1, 6
Pathophysiological Basis for Classification
The severity classification reflects underlying pathophysiology: RV failure occurs when >30-50% of pulmonary vascular cross-sectional area is occluded 1. The non-preconditioned RV cannot generate mean PAP >40 mmHg, leading to:
- RV dilation and increased wall tension
- Interventricular septal shift impairing LV filling
- Reduced cardiac output and systemic hypotension
- RV ischemia (evidenced by elevated troponin) 1
This pathophysiological cascade explains why hemodynamic status and RV function—not just anatomic burden—determine prognosis and guide treatment intensity.